LIBETTE 12,5 MG COM REV CT BL AL AL X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1004315850025 -
GGREM
508026080210907 -
Código de barras
7891317052638
O que a fonte publica
- Detentor do registro
- EUROFARMA LABORATORIOS S.A.
- Princípios ativos
- BENZOATO DE ALOGLIPTINA
- Embalagem
- 12,5 MG COM REV CT BL AL AL X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Similar
- Classe terapêutica
- A10N1 - ANTIDIABÉTICOS INIBIDORES DPP-IV PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "LIBETTE 12,5 MG COM REV CT BL AL AL X 30",
"holder": "EUROFARMA LABORATORIOS S.A.",
"stripe": "Tarja Vermelha",
"barcodes": [
"7891317052638"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "508026080210907",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "61.190.096/0001-92",
"priceRegime": "Regulado",
"productName": "LIBETTE",
"productType": "Similar",
"hospitalOnly": false,
"presentation": "12,5 MG COM REV CT BL AL AL X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "102.34",
"icms-12": "116.30",
"icms-17": "123.30",
"icms-18": "124.80",
"icms-19": "126.35",
"icms-20": "127.93",
"icms-21": "129.54",
"icms-22": "131.21",
"icms-23": "132.91",
"icms-17.5": "124.05",
"icms-19.5": "127.13",
"icms-20.5": "128.73",
"icms-22.5": "132.05",
"icms-12-alc": "103.84",
"icms-17-alc": "110.09",
"icms-18-alc": "111.43",
"icms-19-alc": "112.81",
"icms-20-alc": "114.22",
"icms-21-alc": "115.66",
"icms-22-alc": "117.15",
"icms-23-alc": "118.67",
"withoutTaxes": "91.37",
"icms-17.5-alc": "110.76",
"icms-19.5-alc": "113.51",
"icms-20.5-alc": "114.94",
"icms-22.5-alc": "117.90"
},
"pisCofinsList": "Negativa",
"substanceText": "BENZOATO DE ALOGLIPTINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "137.29",
"icms-12": "156.01",
"icms-17": "165.40",
"icms-18": "167.41",
"icms-19": "169.49",
"icms-20": "171.61",
"icms-21": "173.77",
"icms-22": "176.01",
"icms-23": "178.29",
"icms-17.5": "166.41",
"icms-19.5": "170.54",
"icms-20.5": "172.69",
"icms-22.5": "177.14",
"icms-12-alc": "143.55",
"icms-17-alc": "152.19",
"icms-18-alc": "154.05",
"icms-19-alc": "155.95",
"icms-20-alc": "157.90",
"icms-21-alc": "159.89",
"icms-22-alc": "161.95",
"icms-23-alc": "164.05",
"withoutTaxes": "126.32",
"icms-17.5-alc": "153.12",
"icms-19.5-alc": "156.92",
"icms-20.5-alc": "158.90",
"icms-22.5-alc": "162.99"
},
"invalidBarcodes": [],
"activeSubstances": [
"BENZOATO DE ALOGLIPTINA"
],
"therapeuticClass": "A10N1 - ANTIDIABÉTICOS INIBIDORES DPP-IV PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1004315850025",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10N1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:508026080210907"